Chime Financial, Inc. (CHYM) Competitors & Peers
The 5 largest companies in the same industry as Chime Financial, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| SAPGF | Peer | $210.85 | P/E 27.7RSI 56Cap 247.6 B |
| SAP | Peer | $210.68 | P/E 27.5RSI 52Cap 243.2 B |
| CRM | Peer | $234.02 | P/E 21.4RSI 54Cap 192.6 B |
| SHOP | Peer | $142.25 | P/E 95.1RSI 54Cap 181.0 B |
| NOW | Peer | $135.62 | P/E 84.8RSI 52Cap 140.2 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- EBSPartner
Emergent BioSolutions acquired Tembexa antiviral drug from Chimerix, paying royalties on global sales and supply contracts.
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
AWS provides cloud infrastructure hosting Chimerix genomics datasets and clinical trial portals.
Model-inferred, unverified — treat as a lead, not evidence